Cargando…

Dopaminergic Positron Emission Tomography Imaging in the Alpha‐Synuclein Preformed Fibril Model Reveals Similarities to Early Parkinson's Disease

BACKGROUND: Positron emission tomography (PET) imaging in early Parkinson's disease (PD) subjects reveals that increased dopamine (DA) turnover and reduced dopamine transporter (DAT) density precede decreases in DA synthesis and storage. The rat α‐synuclein preformed fibril (α‐syn PFF) model pr...

Descripción completa

Detalles Bibliográficos
Autores principales: Sossi, Vesna, Patterson, Joseph R., McCormick, Siobhan, Kemp, Christopher J., Miller, Kathryn M., Stoll, Anna C., Kuhn, Nathan, Kubik, Michael, Kochmanski, Joseph, Luk, Kelvin C., Sortwell, Caryl E.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: John Wiley & Sons, Inc. 2022
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9391270/
https://www.ncbi.nlm.nih.gov/pubmed/35524682
http://dx.doi.org/10.1002/mds.29051
_version_ 1784770834019123200
author Sossi, Vesna
Patterson, Joseph R.
McCormick, Siobhan
Kemp, Christopher J.
Miller, Kathryn M.
Stoll, Anna C.
Kuhn, Nathan
Kubik, Michael
Kochmanski, Joseph
Luk, Kelvin C.
Sortwell, Caryl E.
author_facet Sossi, Vesna
Patterson, Joseph R.
McCormick, Siobhan
Kemp, Christopher J.
Miller, Kathryn M.
Stoll, Anna C.
Kuhn, Nathan
Kubik, Michael
Kochmanski, Joseph
Luk, Kelvin C.
Sortwell, Caryl E.
author_sort Sossi, Vesna
collection PubMed
description BACKGROUND: Positron emission tomography (PET) imaging in early Parkinson's disease (PD) subjects reveals that increased dopamine (DA) turnover and reduced dopamine transporter (DAT) density precede decreases in DA synthesis and storage. The rat α‐synuclein preformed fibril (α‐syn PFF) model provides a platform to investigate DA dynamics during multiple stages of α‐syn inclusion‐triggered nigrostriatal degeneration. OBJECTIVES: We investigated multiple aspects of in vivo dopaminergic deficits longitudinally and similarities to human PD using translational PET imaging readouts. METHODS: Longitudinal imaging was performed every 2 months in PFF and control rats for 7 months. [(18)F]‐Fluoro‐3,4‐dihydroxyphenyl‐L‐alanine (FDOPA) imaging was performed to investigate DA synthesis and storage (K(occ)) and DA turnover, estimated by its inverse, the effective distribution volume ratio (EDVR). (11)C‐Methylphenidate (MP) was used to estimate DAT density (BP(ND)). RESULTS: Early DA turnover increases and DAT binding decreases were observed in the ipsilateral striatum of PFF rats, progressing longitudinally. EDVR decreased 26%, 38%, and 47%, and BP(ND) decreased 36%, 50%, and 65% at the 2‐, 4‐, and 6‐month time points, respectively, compared to ipsilateral control striatum. In contrast, deficits in DA synthesis and storage were not observed in the ipsilateral striatum of PFF rats compared to control injections and were relatively preserved up to 6 months (K(occ) decreased 20% at 6 months). CONCLUSIONS: The relative preservation of DA synthesis and storage compared to robust progressive deficits in DAT density and increases in DA turnover in the rat α‐syn PFF model display remarkable face validity to dopaminergic alterations in human PD. © 2022 The Authors. Movement Disorders published by Wiley Periodicals LLC on behalf of International Parkinson and Movement Disorder Society
format Online
Article
Text
id pubmed-9391270
institution National Center for Biotechnology Information
language English
publishDate 2022
publisher John Wiley & Sons, Inc.
record_format MEDLINE/PubMed
spelling pubmed-93912702022-10-14 Dopaminergic Positron Emission Tomography Imaging in the Alpha‐Synuclein Preformed Fibril Model Reveals Similarities to Early Parkinson's Disease Sossi, Vesna Patterson, Joseph R. McCormick, Siobhan Kemp, Christopher J. Miller, Kathryn M. Stoll, Anna C. Kuhn, Nathan Kubik, Michael Kochmanski, Joseph Luk, Kelvin C. Sortwell, Caryl E. Mov Disord Regular Issue Articles BACKGROUND: Positron emission tomography (PET) imaging in early Parkinson's disease (PD) subjects reveals that increased dopamine (DA) turnover and reduced dopamine transporter (DAT) density precede decreases in DA synthesis and storage. The rat α‐synuclein preformed fibril (α‐syn PFF) model provides a platform to investigate DA dynamics during multiple stages of α‐syn inclusion‐triggered nigrostriatal degeneration. OBJECTIVES: We investigated multiple aspects of in vivo dopaminergic deficits longitudinally and similarities to human PD using translational PET imaging readouts. METHODS: Longitudinal imaging was performed every 2 months in PFF and control rats for 7 months. [(18)F]‐Fluoro‐3,4‐dihydroxyphenyl‐L‐alanine (FDOPA) imaging was performed to investigate DA synthesis and storage (K(occ)) and DA turnover, estimated by its inverse, the effective distribution volume ratio (EDVR). (11)C‐Methylphenidate (MP) was used to estimate DAT density (BP(ND)). RESULTS: Early DA turnover increases and DAT binding decreases were observed in the ipsilateral striatum of PFF rats, progressing longitudinally. EDVR decreased 26%, 38%, and 47%, and BP(ND) decreased 36%, 50%, and 65% at the 2‐, 4‐, and 6‐month time points, respectively, compared to ipsilateral control striatum. In contrast, deficits in DA synthesis and storage were not observed in the ipsilateral striatum of PFF rats compared to control injections and were relatively preserved up to 6 months (K(occ) decreased 20% at 6 months). CONCLUSIONS: The relative preservation of DA synthesis and storage compared to robust progressive deficits in DAT density and increases in DA turnover in the rat α‐syn PFF model display remarkable face validity to dopaminergic alterations in human PD. © 2022 The Authors. Movement Disorders published by Wiley Periodicals LLC on behalf of International Parkinson and Movement Disorder Society John Wiley & Sons, Inc. 2022-05-07 2022-08 /pmc/articles/PMC9391270/ /pubmed/35524682 http://dx.doi.org/10.1002/mds.29051 Text en © 2022 The Authors. Movement Disorders published by Wiley Periodicals LLC on behalf of International Parkinson and Movement Disorder Society https://creativecommons.org/licenses/by-nc-nd/4.0/This is an open access article under the terms of the http://creativecommons.org/licenses/by-nc-nd/4.0/ (https://creativecommons.org/licenses/by-nc-nd/4.0/) License, which permits use and distribution in any medium, provided the original work is properly cited, the use is non‐commercial and no modifications or adaptations are made.
spellingShingle Regular Issue Articles
Sossi, Vesna
Patterson, Joseph R.
McCormick, Siobhan
Kemp, Christopher J.
Miller, Kathryn M.
Stoll, Anna C.
Kuhn, Nathan
Kubik, Michael
Kochmanski, Joseph
Luk, Kelvin C.
Sortwell, Caryl E.
Dopaminergic Positron Emission Tomography Imaging in the Alpha‐Synuclein Preformed Fibril Model Reveals Similarities to Early Parkinson's Disease
title Dopaminergic Positron Emission Tomography Imaging in the Alpha‐Synuclein Preformed Fibril Model Reveals Similarities to Early Parkinson's Disease
title_full Dopaminergic Positron Emission Tomography Imaging in the Alpha‐Synuclein Preformed Fibril Model Reveals Similarities to Early Parkinson's Disease
title_fullStr Dopaminergic Positron Emission Tomography Imaging in the Alpha‐Synuclein Preformed Fibril Model Reveals Similarities to Early Parkinson's Disease
title_full_unstemmed Dopaminergic Positron Emission Tomography Imaging in the Alpha‐Synuclein Preformed Fibril Model Reveals Similarities to Early Parkinson's Disease
title_short Dopaminergic Positron Emission Tomography Imaging in the Alpha‐Synuclein Preformed Fibril Model Reveals Similarities to Early Parkinson's Disease
title_sort dopaminergic positron emission tomography imaging in the alpha‐synuclein preformed fibril model reveals similarities to early parkinson's disease
topic Regular Issue Articles
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9391270/
https://www.ncbi.nlm.nih.gov/pubmed/35524682
http://dx.doi.org/10.1002/mds.29051
work_keys_str_mv AT sossivesna dopaminergicpositronemissiontomographyimaginginthealphasynucleinpreformedfibrilmodelrevealssimilaritiestoearlyparkinsonsdisease
AT pattersonjosephr dopaminergicpositronemissiontomographyimaginginthealphasynucleinpreformedfibrilmodelrevealssimilaritiestoearlyparkinsonsdisease
AT mccormicksiobhan dopaminergicpositronemissiontomographyimaginginthealphasynucleinpreformedfibrilmodelrevealssimilaritiestoearlyparkinsonsdisease
AT kempchristopherj dopaminergicpositronemissiontomographyimaginginthealphasynucleinpreformedfibrilmodelrevealssimilaritiestoearlyparkinsonsdisease
AT millerkathrynm dopaminergicpositronemissiontomographyimaginginthealphasynucleinpreformedfibrilmodelrevealssimilaritiestoearlyparkinsonsdisease
AT stollannac dopaminergicpositronemissiontomographyimaginginthealphasynucleinpreformedfibrilmodelrevealssimilaritiestoearlyparkinsonsdisease
AT kuhnnathan dopaminergicpositronemissiontomographyimaginginthealphasynucleinpreformedfibrilmodelrevealssimilaritiestoearlyparkinsonsdisease
AT kubikmichael dopaminergicpositronemissiontomographyimaginginthealphasynucleinpreformedfibrilmodelrevealssimilaritiestoearlyparkinsonsdisease
AT kochmanskijoseph dopaminergicpositronemissiontomographyimaginginthealphasynucleinpreformedfibrilmodelrevealssimilaritiestoearlyparkinsonsdisease
AT lukkelvinc dopaminergicpositronemissiontomographyimaginginthealphasynucleinpreformedfibrilmodelrevealssimilaritiestoearlyparkinsonsdisease
AT sortwellcaryle dopaminergicpositronemissiontomographyimaginginthealphasynucleinpreformedfibrilmodelrevealssimilaritiestoearlyparkinsonsdisease